Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Amortizatization of Intangibles: 2019-2024

Historic Amortizatization of Intangibles for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Dec 2024 value amounting to $27.5 million.

  • Maravai Lifesciences Holdings' Amortizatization of Intangibles rose 4.61% to $7.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.3 million, marking a year-over-year increase of 3.07%. This contributed to the annual value of $27.5 million for FY2024, which is 0.64% up from last year.
  • Maravai Lifesciences Holdings' Amortizatization of Intangibles amounted to $27.5 million in FY2024, which was up 0.64% from $27.4 million recorded in FY2023.
  • Maravai Lifesciences Holdings' Amortizatization of Intangibles' 5-year high stood at $27.5 million during FY2024, with a 5-year trough of $18.3 million in FY2021.
  • Over the past 3 years, Maravai Lifesciences Holdings' median Amortizatization of Intangibles value was $27.4 million (recorded in 2023), while the average stood at $26.4 million.
  • Per our database at Business Quant, Maravai Lifesciences Holdings' Amortizatization of Intangibles dropped by 9.75% in 2021 and then spiked by 32.34% in 2022.
  • Yearly analysis of 5 years shows Maravai Lifesciences Holdings' Amortizatization of Intangibles stood at $20.3 million in 2020, then decreased by 9.75% to $18.3 million in 2021, then spiked by 32.34% to $24.3 million in 2022, then increased by 12.72% to $27.4 million in 2023, then rose by 0.64% to $27.5 million in 2024.